Baker McKenzie advised Lundbeck on the acquisition of Alder BioPharmaceuticals. The transaction is valued up to $1.95 billion net of cash, on a fully diluted basis….
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now